Active Filter(s):
Details:
ImmuneMed said the company and Seoul National University Hospital have won the government’s approval for Virus Suppressing Factor as the treatment for new coronavirus patients.
Lead Product(s): Virus suppressing factor
Therapeutic Area: Infections and Infectious Diseases Product Name: Undisclosed
Highest Development Status: Undisclosed Product Type: Large molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable March 03, 2020